Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Mack

Showing results (1301-1310 of 1,619) with videos related to

Pageof 162
Sort By:
The Annals of Thoracic Surgery|October 30, 2004
A prospective multicenter trial of bipolar radiofrequency ablation for atrial fibrillation: early resultsNahush A Mokadam, Patrick M McCarthy, A Marc Gillinov, et al.
Circulation|April 8, 2015
Optimal medical therapy improves clinical outcomes in patients undergoing revascularization with percutaneous coronary intervention or coronary artery bypass grafting: insights from the Synergy Between Percutaneous Coronary Intervention with TAXUS and Cardiac Surgery (SYNTAX) trial at the 5-year follow-upJavaid Iqbal, Yao-Jun Zhang, David R Holmes, et al.
Journal of the American Heart Association|April 2, 2024
γ-Glutamyl Transferase and Long-Term Survival in the SYNTAXES Trial: Is It Just the Liver?Kai Ninomiya, Patrick W Serruys, Scot Garg, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|January 12, 2023
Impact of periprocedural major adverse events on 10-year mortality after revascularisationNozomi Kotoku, Patrick W Serruys, Kai Ninomiya, et al.
The Annals of Thoracic Surgery|December 24, 2013
Impact of extracardiac vascular disease on vein graft failure and outcomes after coronary artery bypass surgeryRalf E Harskamp, John H Alexander, Phillip J Schulte, et al.
The New England Journal of Medicine|February 21, 2009
Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery diseasePatrick W Serruys, Marie-Claude Morice, A Pieter Kappetein, et al.
Plos One|September 25, 2015
Clusterin Seals the Ocular Surface Barrier in Mouse Dry EyeAditi Bauskar, Wendy J Mack, Jerome Mauris, et al.
European Heart Journal|February 8, 2022
Impact of baseline renal dysfunction on cardiac outcomes and end-stage renal disease in heart failure patients with mitral regurgitation: the COAPT trialNirat Beohar, Gorav Ailawadi, Lak N Kotinkaduwa, et al.
Biorxiv : the Preprint Server for Biology|April 10, 2023
Iron associated lipid peroxidation in Alzheimers disease is increased in lipid rafts with decreased ferroptosis suppressors, tested by chelation in miceMax Thorwald, Jose A Godoy-Lugo, Gilberto Garcia, et al.
Circulation|May 8, 2023
Economic Outcomes of Transcatheter Versus Surgical Aortic Valve Replacement in Patients with Severe Aortic Stenosis and Low Surgical Risk: Results from the PARTNER 3 TrialBenjamin Z Galper, Khaja M Chinnakondepalli, Kaijun Wang, et al.
Pageof 162

Showing results (1301-1310 of 1,619) with videos related to

Sort By:
Pageof 162
The Annals of Thoracic Surgery|October 30, 2004
A prospective multicenter trial of bipolar radiofrequency ablation for atrial fibrillation: early resultsNahush A Mokadam, Patrick M McCarthy, A Marc Gillinov, et al.
Circulation|April 8, 2015
Optimal medical therapy improves clinical outcomes in patients undergoing revascularization with percutaneous coronary intervention or coronary artery bypass grafting: insights from the Synergy Between Percutaneous Coronary Intervention with TAXUS and Cardiac Surgery (SYNTAX) trial at the 5-year follow-upJavaid Iqbal, Yao-Jun Zhang, David R Holmes, et al.
Journal of the American Heart Association|April 2, 2024
γ-Glutamyl Transferase and Long-Term Survival in the SYNTAXES Trial: Is It Just the Liver?Kai Ninomiya, Patrick W Serruys, Scot Garg, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|January 12, 2023
Impact of periprocedural major adverse events on 10-year mortality after revascularisationNozomi Kotoku, Patrick W Serruys, Kai Ninomiya, et al.
The Annals of Thoracic Surgery|December 24, 2013
Impact of extracardiac vascular disease on vein graft failure and outcomes after coronary artery bypass surgeryRalf E Harskamp, John H Alexander, Phillip J Schulte, et al.
The New England Journal of Medicine|February 21, 2009
Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery diseasePatrick W Serruys, Marie-Claude Morice, A Pieter Kappetein, et al.
Plos One|September 25, 2015
Clusterin Seals the Ocular Surface Barrier in Mouse Dry EyeAditi Bauskar, Wendy J Mack, Jerome Mauris, et al.
European Heart Journal|February 8, 2022
Impact of baseline renal dysfunction on cardiac outcomes and end-stage renal disease in heart failure patients with mitral regurgitation: the COAPT trialNirat Beohar, Gorav Ailawadi, Lak N Kotinkaduwa, et al.
Biorxiv : the Preprint Server for Biology|April 10, 2023
Iron associated lipid peroxidation in Alzheimers disease is increased in lipid rafts with decreased ferroptosis suppressors, tested by chelation in miceMax Thorwald, Jose A Godoy-Lugo, Gilberto Garcia, et al.
Circulation|May 8, 2023
Economic Outcomes of Transcatheter Versus Surgical Aortic Valve Replacement in Patients with Severe Aortic Stenosis and Low Surgical Risk: Results from the PARTNER 3 TrialBenjamin Z Galper, Khaja M Chinnakondepalli, Kaijun Wang, et al.
Pageof 162